NMR in cancer: XX. FONAR scans of patients with cancer
Damadian, R.; Goldsmith, M.; Minkoff, L.
Physiological Chemistry and Physics 10(3): 285-287
1978
ISSN/ISBN: 0031-9325 PMID: 216040 Document Number: 124614
Document emailed within 1 workday
Related Documents
Santiago, J.F.Y.; Gonen, M.; Yeung, H.; Macapinlac, H.; Larson, S. 2006: A retrospective analysis of the impact of 18F-FDG PET scans on clinical management of 133 breast cancer patients Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 50(1): 61-67Hazelrigg, S. 1984: Breast cancer: are preoperative bone scans necessary? Connecticut Medicine 48(11): 697-699
Ramsdell, J.W.; Peters, R.M.; Taylor, A.T.; Alazraki, N.P.; Tisi, G.M. 1977: Multiorgan scans for staging lung cancer. Correlation with clinical evaluation Journal of Thoracic and Cardiovascular Surgery 73(5): 653-659
Rothman, L.R.; Levender, M.M.; Scharf, M.D.; Herman, S.P.; Jabbari, A. 2013: Iododerma following serial computed tomography scans in a lung cancer patient Journal of Drugs in Dermatology: Jdd 12(5): 574-576
Holtedahl, K.A. 1984: Cancer diagnosis in general practice V. Patients with and without cancer. who consults the physician for the 7 warning cancer signals? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 104(12): 804-806
Ngo, L.S.M.; Yeo, A.; Wong, A.S.C.; Tay, M.Hiang. 2007: Efficacy of low-dose ketoconazole in hormone refractory prostate cancer patients at the National Cancer Centre and The Cancer Institute, Singapore Annals of the Academy of Medicine Singapore 36(10): 811-814
Iwakiri, U.; Kobayashi, D.; Kubota, T.; Suenaga, K.; Kamimura, H.; Shimazoe, T. 2012: Cautions for pharmaceutical care in cancer patients-comparative evaluation between cancer and non-cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(11): 1693-1697
Plavetić, N.Dedić.; Dražin, R.Kelemenić.; Dintinjana, R.Dobrila.; Radić, M.; Prejac, J.; Dolić, Z.Mišetić.; Pavlović, M.; Škegro, M.; Šeparović, R.; Vrbanec, D. 2016: Cancer Patients Follow-Up – Croatian Society of Medical Oncology Clinical Guidelines Part Iii: Neuroendocrine Neoplasms, Hepatocellular Carcinoma, Pancreatic Cancer, Cancer of the Bile Ducts Lijecnicki vjesnik 138(7-8): 173-178
Kamynina, T.V.; Zharinov, G.M.; Iakovlev, A.I. 1987: Parametric analysis of the survival of cancer patients based on the results of radiation therapy of cervical cancer patients Voprosy Onkologii 33(12): 51-55
Sumimura, J.; Morimoto, Y.; Miyazaki, M.; Ishikawa, S.; Nagai, I. 1999: Comparative study of 5'-deoxy-5-fluorouridine between older cancer patients versus younger cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(4): 561-564
Kallay, E.; Degi, C.L.; Pintea, S. 2017: Are male cancer patients more affected by losing their jobs than female patients? Gender as a moderator of the relationship between losing the job and well-being in a sample of Romanian cancer patients Journal of BUON: Official Journal of the Balkan Union of Oncology 22(5): 1345-1351
Sigh, K.S. 1975: Nursing and cancer patients. 5. Cancer patients in stages of fear, depression and acceptance Sygeplejersken 75(43): 12-14
Lumbroso, J.D.; Guermazi, F.; Hartmann, O.; Coornaert, S.; Rabarison, Y.; Leclère, J.G.; Couanet, D.; Bayle, C.; Caillaud, J.M.; Lemerle, J. 1988: Meta-iodobenzylguanidine (mIBG) scans in neuroblastoma: sensitivity and specificity, a review of 115 scans Progress in Clinical and Biological Research 271: 689-705
Suzuki, M.; Sekiguchi, I.; Tamada, T.; Sakurabayashi, I.; Kawai, T. 1985: Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors Rinsho Byori. Japanese Journal of Clinical Pathology 33(2): 173-177
Zissimopoulos, A.; Stellos, K.; Matthaios, D.; Petrakis, G.; Parmenopoulou, V.; Babatsikou, F.; Matthaiou, E.; Theodosiadou, E.; Hountis, P.; Koutis, C. 2009: Type i collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy Journal of Buon: Official Journal of the Balkan Union of Oncology 14(3): 463-472
Hakulinen, T. 1995: Health care system, cancer registration and follow-up of cancer patients in Finland Iarc Scientific Publications 132: 53-54
Zucker, S.; Lysik, R.M.; Zarrabi, M.H.; Moll, U. 1993: M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer Cancer Research 53(1): 140-146
Vích, Z. 1988: Cancer registry data: actuarial survival estimation in lung cancer patients Neoplasma 35(2): 129-133
Fayaz, M.Salah.; Demian, G.Attia.; Eissa, H.El-Sayed.; Abu-Zlouf, S. 2018: Colon Cancer in Patients below Age of 50 Years: Kuwait Cancer Control Center Experience Gulf Journal of Oncology 1(27): 38-44
Szajda, S.ła.D.; Darewicz, B.; Kudelski, J.; Chlabicz, M.; Domel, T.; Chabielska, E.; Skrzydlewski, Z.ła. 2005: Cancer procoagulant and cathepsin D activity in blood serum in patients with bladder cancer Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 18(108): 651-653